T2 Mapping Edema Index (Myocardial) Calculator

Clinical calculation support · Verify results before clinical use

Measurement inputs

Enter quantitative T2 values in milliseconds. Optional comparisons require paired reference values.

CMRT2 mapping
Quantitative T2 value measured on the myocardial T2 map.
Use a reference population matched to scanner, field strength, sequence, and local protocol.
Must be greater than zero; enter together with the local mean.
For an exploratory myocardium-to-skeletal-muscle quantitative T2 ratio; no universal cutoff is applied.
Signal intensity from T2-weighted imaging, not a quantitative T2 map.
Required with myocardial T2-weighted SI to calculate the historical signal-intensity ratio.

About myocardial T2 mapping

T2 mapping estimates the myocardial transverse relaxation time in milliseconds. Prolonged myocardial T2 is associated with increased free-water content and can support assessment of myocardial edema, but the measured value depends on field strength, pulse sequence, scanner, acquisition, and analysis method.

How to interpret the indices

  • Myocardial T2: interpret using locally validated reference ranges for the relevant scanner and sequence; a single universal millisecond cutoff is not appropriate for every protocol.
  • Local-reference Z-score: calculated as (patient T2 − local mean) / local SD. A value ≥ +2 SD is displayed as a reference-based abnormality flag, not as a universal diagnostic threshold.
  • Quantitative myocardium:skeletal-muscle T2 ratio: shown as a descriptive ratio only. Do not apply a universal cutoff unless validated for the local method.
  • T2-weighted SI ratio: a historical semi-quantitative measure. A ratio ≥2.0 has been used in Lake Louise criteria; it is distinct from quantitative T2 mapping.

Lake Louise framework

The updated 2018 Lake Louise approach supports CMR evidence of myocardial inflammation when at least one T2-based marker of edema and at least one T1-based marker of myocardial injury are present. T2 mapping alone is not sufficient to establish a diagnosis. Apply the framework with clinical context and the full CMR examination.

Scientific references

O’Brien AT, Gil KE, Varghese J, Simonetti OP, Zareba KM.T2 mapping in myocardial disease: a comprehensive review. J Cardiovasc Magn Reson. 2022;24:33. DOI: 10.1186/s12968-022-00866-0; PMID: 35659266.
Ferreira VM, Schulz-Menger J, Holmvang G, et al.Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72(16): 3158–3176. DOI: 10.1016/j.jacc.2018.09.072.
Friedrich MG, Sechtem U, Schulz-Menger J, et al.Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475–1487. DOI: 10.1016/j.jacc.2009.02.007.
Clinical disclaimer: This tool performs arithmetic calculations only. Results are not a standalone diagnosis and must be interpreted by qualified clinicians using locally validated CMR reference data, acquisition details, image quality, symptoms, biomarkers, and the complete clinical assessment. Do not use the quantitative T2 ratio or Z-score as a universal cutoff across scanners or sequences.